ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Antiplatelet Resistance in Patients Who Underwent Coronary Artery Bypass Grafting: A Systematic Review and Meta-Analysis
Thursday, September 28, 2023
Submitted by
Source
Source Name: The American Journal of Cardiology
Use of antiplatelet medication following coronary artery bypass grafting is common practice to reduce thrombotic events. However, antiplatelet resistance is of growing concern. The authors of this review conducted a systematic review and meta-analysis of eleven studies involving 3122 patients. The primary outcome measures were major adverse cardiovascular events and mortality. The authors report a 39 percent prevalence of antiplatelet resistance from the studies included.
Printer-friendly
